FDA approved ProAir digihaler by Asthmapolis, the first app-connected digital inhaler. The ProAir Digihaler has built-in sensors to detect when the device is used and the strength of the user’s inhalation. This data is then sent via Bluetooth to its mobile app companion which can be shared with a healthcare professional. This smart sensor provides visual information for patients and doctors to see trends in use, help ensure the patient is getting the proper dosage, and to identify proper inhaler usage for creating a more precise disease management plan.
Read the full FDA press release here.